Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

A protein combining parathyroid hormone and collagen helped hair regrow in mice with a hair loss condition.

The patient with total hair loss did not regrow hair despite treatment, indicating a poor outlook for this type of hair loss.

Trichoscopy is essential for diagnosing and managing alopecia areata in children.

Alopecia areata affects quality of life more than androgenetic alopecia.

Ritlecitinib is being tested for effectiveness and safety in treating severe alopecia areata.

Baricitinib shows promise for severe alopecia areata but isn't a cure and has side effects.

Alopecia Areata causes emotional stress and stigma, but those with severe hair loss may adapt better.

Alopecia areata leads to significantly higher healthcare costs due to more doctor visits and prescriptions.

The criteria help doctors diagnose and treat alopecia areata more effectively.

Alopecia areata causes unpredictable hair loss and emotional distress, with no cure and limited treatment options.

A new treatment plan for alopecia areata considers disease severity, quality of life, and progression to offer personalized care.

Alopecia areata causes significant psychological distress in cancer patients, needing integrated care.

JAK inhibitors are effective for long-term management of alopecia areata.

The Polish version of the Alopecia Areata Quality of Life Index is a reliable tool for assessing quality of life in Polish-speaking patients with alopecia areata.

Ritlecitinib effectively regrows hair in severe alopecia areata and is well tolerated.

Alopecia areata severely impacts quality of life, mental health, and work productivity.

Japanese patients and physicians often disagree on the severity of Alopecia Areata and treatment satisfaction, needing better communication and treatments.

The Middle East and Africa need better data, treatment consensus, and support for Alopecia Areata.

ILC1-like cells can cause alopecia areata by attacking hair follicles.

Alopecia areata is linked to immune system differences, with specific biomarkers like CXCL9 and CXCL10 being key for diagnosis and potential treatment targets.

Alopecia areata treatment varies, with no optimal method established yet.

Researchers created a new tool to measure the effects of alopecia areata from the patient's view, focusing on hair loss, daily life, and emotional health.

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

A standard protocol for alopecia areata clinical trials was created to improve consistency and encourage more research.

STS01 1% effectively promotes hair regrowth with minimal side effects.

Triamcinolone acetonide is more effective than cryotherapy for hair regrowth in alopecia areata but has different side effects.

Significant, lasting hair regrowth is needed to improve how patients with Alopecia Areata feel about their condition.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

Platelet-rich plasma treatment significantly increased hair regrowth and decreased discomfort in alopecia patients, making it a potentially better and safer treatment option.